↓ Skip to main content

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease

Overview of attention for article published in Drugs, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
1 X user
patent
6 patents

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
149 Mendeley
Title
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
Published in
Drugs, March 2019
DOI 10.1007/s40265-019-01095-z
Pubmed ID
Authors

Matt Shirley

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 149 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 20%
Researcher 18 12%
Student > Bachelor 15 10%
Student > Master 12 8%
Other 10 7%
Other 15 10%
Unknown 49 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 36 24%
Medicine and Dentistry 12 8%
Chemistry 10 7%
Biochemistry, Genetics and Molecular Biology 9 6%
Chemical Engineering 6 4%
Other 25 17%
Unknown 51 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2023.
All research outputs
#3,502,792
of 24,334,327 outputs
Outputs from Drugs
#465
of 3,399 outputs
Outputs of similar age
#75,681
of 356,149 outputs
Outputs of similar age from Drugs
#14
of 48 outputs
Altmetric has tracked 24,334,327 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,399 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.